CSL Limited (OTCMKTS:CSLLY – Get Free Report)’s stock price traded up 0.2% during mid-day trading on Friday . The stock traded as high as $91.91 and last traded at $91.19. 32,278 shares were traded during trading, a decline of 13% from the average session volume of 37,233 shares. The stock had previously closed at $91.05.
CSL Price Performance
The stock has a 50-day simple moving average of $91.65 and a 200 day simple moving average of $90.31.
CSL Company Profile
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Recommended Stories
- Five stocks we like better than CSL
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 4/29 – 5/3
- What Are Trending Stocks? Trending Stocks Explained
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Find and Profitably Trade Stocks at 52-Week Lows
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.